Loading…
Lobbying Spend
—
Filings
28
Firms Hired
1
Active Period
2018–2024
Client-reported lobbying expenses on LDA filings
Lobbying firms retained by this client; amounts are client-reported expenses when available
Government entities explicitly identified as targets in LDA filings
Most frequently reported lobbying issues
Bill numbers found in source-reported LDA specific issue text; broad topic matches are excluded
Facilitating Innovative Nuclear Diagnostics Act of 2023
2024 · fourth_quarter · Firm: CAPITOL COUNSEL LLC
Issues related to appropriate payment legislation for diagnostic radiopharmaceuticals. H.R.1199 - Facilitating Innovative Nuclear Diagnostics Act of 2023.
Client expense: — · Firm income: $60,000
Matched citations: H.R.1199
Facilitating Innovative Nuclear Diagnostics Act of 2023
2024 · fourth_quarter · Firm: CAPITOL COUNSEL LLC
Issues related to appropriate payment legislation for diagnostic radiopharmaceuticals. H.R.1199 - Facilitating Innovative Nuclear Diagnostics Act of 2023.
Client expense: — · Firm income: $60,000
Matched citations: H.R.1199
Facilitating Innovative Nuclear Diagnostics Act of 2023
2024 · third_quarter · Firm: CAPITOL COUNSEL LLC
Issues related to appropriate payment legislation for diagnostic radiopharmaceuticals. H.R.1199 - Facilitating Innovative Nuclear Diagnostics Act of 2023.
Client expense: — · Firm income: $60,000
Matched citations: H.R.1199
Facilitating Innovative Nuclear Diagnostics Act of 2023
2024 · second_quarter · Firm: CAPITOL COUNSEL LLC
Issues related to appropriate payment legislation for diagnostic radiopharmaceuticals. H.R.1199 - Facilitating Innovative Nuclear Diagnostics Act of 2023.
Client expense: — · Firm income: $60,000
Matched citations: H.R.1199
Facilitating Innovative Nuclear Diagnostics Act of 2023
2024 · first_quarter · Firm: CAPITOL COUNSEL LLC
Issues related to appropriate payment legislation for diagnostic radiopharmaceuticals. H.R.1199 - Facilitating Innovative Nuclear Diagnostics Act of 2023.
Client expense: — · Firm income: $60,000
Matched citations: H.R.1199
Facilitating Innovative Nuclear Diagnostics Act of 2023
2023 · fourth_quarter · Firm: CAPITOL COUNSEL LLC
Issues related to appropriate payment legislation for diagnostic radiopharmaceuticals. H.R.1199 - Facilitating Innovative Nuclear Diagnostics Act of 2023.
Client expense: — · Firm income: $60,000
Matched citations: H.R.1199
Facilitating Innovative Nuclear Diagnostics Act of 2023
2023 · third_quarter · Firm: CAPITOL COUNSEL LLC
Issues related to appropriate payment legislation for diagnostic radiopharmaceuticals. H.R.1199 - Facilitating Innovative Nuclear Diagnostics Act of 2023.
Client expense: — · Firm income: $60,000
Matched citations: H.R.1199
Facilitating Innovative Nuclear Diagnostics Act of 2023
2023 · second_quarter · Firm: CAPITOL COUNSEL LLC
Issues related to appropriate payment legislation for diagnostic radiopharmaceuticals. H.R.1199 - Facilitating Innovative Nuclear Diagnostics Act of 2023.
Client expense: — · Firm income: $60,000
Matched citations: H.R.1199
Facilitating Innovative Nuclear Diagnostics Act of 2023
2023 · first_quarter · Firm: CAPITOL COUNSEL LLC
Issues related to appropriate payment legislation for diagnostic radiopharmaceuticals. H.R.1199 - Facilitating Innovative Nuclear Diagnostics Act of 2023.
Client expense: — · Firm income: $60,000
Matched citations: H.R.1199
Medicare Diagnostic Radiopharmaceutical Payment Equity Act of 2019
2020 · fourth_quarter · Firm: CAPITOL COUNSEL LLC
Issues related to appropriate payment legislation for diagnostic radiopharmaceuticals; HR 3772 - Medicare Diagnostic Radiopharmaceutical Payment Equity Act.
Client expense: — · Firm income: $50,000
Matched citations: HR 3772
Medicare Diagnostic Radiopharmaceutical Payment Equity Act of 2019
2020 · third_quarter · Firm: CAPITOL COUNSEL LLC
Issues related to appropriate payment legislation for diagnostic radiopharmaceuticals; HR 3772 - Medicare Diagnostic Radiopharmaceutical Payment Equity Act.
Client expense: — · Firm income: $50,000
Matched citations: HR 3772
Medicare Diagnostic Radiopharmaceutical Payment Equity Act of 2019
2020 · second_quarter · Firm: CAPITOL COUNSEL LLC
Issues related to appropriate payment legislation for diagnostic radiopharmaceuticals; HR 3772 - Medicare Diagnostic Radiopharmaceutical Payment Equity Act.
Client expense: — · Firm income: $50,000
Matched citations: HR 3772
Medicare Diagnostic Radiopharmaceutical Payment Equity Act of 2019
2020 · first_quarter · Firm: CAPITOL COUNSEL LLC
Issues related to appropriate payment legislation for diagnostic radiopharmaceuticals; HR 3772 - Medicare Diagnostic Radiopharmaceutical Payment Equity Act.
Client expense: — · Firm income: $50,000
Matched citations: HR 3772
Medicare Diagnostic Radiopharmaceutical Payment Equity Act of 2019
2019 · fourth_quarter · Firm: CAPITOL COUNSEL LLC
Issues related to appropriate payment legislation for diagnostic radiopharmaceuticals; HR 3772 - Medicare Diagnostic Radiopharmaceutical Payment Equity Act.
Client expense: — · Firm income: $50,000
Matched citations: HR 3772
Medicare Diagnostic Radiopharmaceutical Payment Equity Act of 2018
2018 · fourth_quarter · Firm: CAPITOL COUNSEL LLC
Issues related to H.R. 6948, appropriate payment legislation for diagnostic radiopharmaceuticals.
Client expense: — · Firm income: $50,000
Matched citations: H.R. 6948
Medicare Diagnostic Radiopharmaceutical Payment Equity Act of 2018
2018 · third_quarter · Firm: CAPITOL COUNSEL LLC
Issues related to H.R. 6948, appropriate payment legislation for diagnostic radiopharmaceuticals.
Client expense: — · Firm income: $50,000
Matched citations: H.R. 6948
Medicare Diagnostic Radiopharmaceutical Payment Equity Act of 2018
2018 · third_quarter · Firm: CAPITOL COUNSEL LLC
To advocate for H.R. 6948, appropriate payment legislation for diagnostic radiopharmaceuticals.
Client expense: — · Firm income: —
Matched citations: H.R. 6948
Source: Senate LDA